These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 31058483)

  • 21. Glutathione-Responsive Organosilica Hybrid Nanosystems for Targeted Dual-Starvation Therapy in Luminal Breast Cancer.
    Ding J; Liu Y; Liu Z; Tan J; Xu W; Huang G; He Z
    Mol Pharm; 2024 Feb; 21(2):745-759. PubMed ID: 38148514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A porphyrin-MOF-based integrated nanozyme system for catalytic cascades and light-enhanced synergistic amplification of cellular oxidative stress.
    Wei YJ; Li J; Hu ZE; Xing X; Zhou ZW; Yu Y; Yu XQ; Zhang J; Liu YH; Wang N
    J Mater Chem B; 2023 Jul; 11(28):6581-6594. PubMed ID: 37358033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prodrug-Based Nanoreactors with Tumor-Specific
    Ren C; Liu H; Lv F; Zhao W; Gao S; Yang X; Jin Y; Tan Y; Zhang J; Liang XJ; Li Z
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34667-34677. PubMed ID: 32610896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
    Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
    Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicomponent metal-organic framework nanocomposites for tumor-responsive synergistic therapy.
    Hur W; Park Y; Seo E; Son SE; Kim S; Seo H; Seong GH
    J Colloid Interface Sci; 2023 Sep; 645():663-675. PubMed ID: 37167915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Camouflaging nanoreactor traverse the blood-brain barrier to catalyze redox cascade for synergistic therapy of glioblastoma.
    Cheng W; Ren W; Ye P; He L; Bao D; Yue T; Lai J; Wu Y; Wei Y; Wu Z; Piao JG
    Biomaterials; 2024 Dec; 311():122702. PubMed ID: 39008916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An intelligent Cu/ZIF-8-based nanodrug delivery system for tumor-specific and synergistic therapy via tumor microenvironment-responsive cascade reaction.
    Wei F; Hou L; Yao Y; Lai Y; Lin T; Zhao S; Tang D
    Mikrochim Acta; 2024 Jul; 191(8):447. PubMed ID: 38963544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy.
    Cheng H; Jiang XY; Zheng RR; Zuo SJ; Zhao LP; Fan GL; Xie BR; Yu XY; Li SY; Zhang XZ
    Biomaterials; 2019 Mar; 195():75-85. PubMed ID: 30616030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A tumor-targeted theranostic nanomedicine with strong absorption in the NIR-II biowindow for image-guided multi-gradient therapy.
    Chen Q; Zheng Z; He X; Rong S; Qin Y; Peng X; Zhang R
    J Mater Chem B; 2020 Oct; 8(41):9492-9501. PubMed ID: 33001118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphate-Degradable Nanoparticles Based on Metal-Organic Frameworks for Chemo-Starvation-Chemodynamic Synergistic Antitumor Therapy.
    Peng H; Qin YT; Feng YS; He XW; Li WY; Zhang YK
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):37713-37723. PubMed ID: 34340302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyaluronic acid-based multifunctional nanoplatform for glucose deprivation-enhanced chemodynamic/photothermal synergistic cancer therapy.
    Liu Q; Chen H; Hu X; Chen L; Li J; Zhang L
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133428. PubMed ID: 38936576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pH-activated autocatalytic nanoreactor for self-boosting Fenton-like chemodynamic therapy.
    Wu H; Chen F; Gu D; You C; Sun B
    Nanoscale; 2020 Sep; 12(33):17319-17331. PubMed ID: 32789333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferrocene and glucose oxidase-installed multifunctional hydrogel reactors for local cancer therapy.
    Lee SY; Park J; Jeong DI; Hwang C; Lee J; Lee K; Kim HJ; Cho HJ
    J Control Release; 2022 Sep; 349():617-633. PubMed ID: 35868357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of a Mesoporous Ceria Hollow Sphere/Enzyme Nanoreactor for Enhanced Cascade Catalytic Antibacterial Therapy.
    Qin J; Feng Y; Cheng D; Liu B; Wang Z; Zhao Y; Wei J
    ACS Appl Mater Interfaces; 2021 Sep; 13(34):40302-40314. PubMed ID: 34412471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cascade nanozymes based on the "butterfly effect" for enhanced starvation therapy through the regulation of autophagy.
    Yao H; Gong X; Geng M; Duan S; Qiao P; Sun F; Zhu Z; Du B
    Biomater Sci; 2022 Jul; 10(14):4008-4022. PubMed ID: 35726640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymer Prodrug-Based Nanoreactors Activated by Tumor Acidity for Orchestrated Oxidation/Chemotherapy.
    Li J; Li Y; Wang Y; Ke W; Chen W; Wang W; Ge Z
    Nano Lett; 2017 Nov; 17(11):6983-6990. PubMed ID: 28977746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hollow Mesoporous Molybdenum Single-Atom Nanozyme-Based Reactor for Enhanced Cascade Catalytic Antibacterial Therapy.
    Zhang Z; Yang T; Wang J; Yu Z; Qiao Y; Wang C; Yue Z; Wu H
    Int J Nanomedicine; 2023; 18():7209-7223. PubMed ID: 38076729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic Nanoreactors Producing Hydrogen Peroxide for Oxidative Cancer Therapy.
    Jo SM; Wurm FR; Landfester K
    Nano Lett; 2020 Jan; 20(1):526-533. PubMed ID: 31789526
    [No Abstract]   [Full Text] [Related]  

  • 40. Bortezomib prodrug catalytic nanoreactor for chemo/chemodynamic therapy and macrophage re-education.
    Huang Y; Guan Z; Ren L; Luo Y; Chen M; Sun Y; He Y; Zeng Z; Dai X; Jiang J; Huang Z; Zhao C
    J Control Release; 2022 Oct; 350():332-349. PubMed ID: 36028045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.